Aim: To study influence of thymodepressin on the course of autoimmune cytopenia.
Material And Methods: Thymodepressin is a new synthetic hemoregulatory dipeptide (gamma-D-Glu-D-Trp). It was used for the treatment of 22 patients with autoimmune cytopenia.
Results: Hemoglobin levels were elevated in autoimmune hemolytic anemia and platelet levels were high in idiopathic thrombocytopenic purpura. A thymodepressin course resulted in a fall of total lymphocyte count and activated CD3+CD69+ lymphocytes.
Conclusion: The above results, safety, absence of toxicity and allergenicity, parenteral and intranasal useability open perspectives for further studies of therapeutic action of thymodepressin as an immunodepressant in autoimmune processes.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Status of free-radical oxidation and proliferation processes in patients with atopic dermatitis and lichen planus.
Bull Exp Biol Med
April 2011
Department of Dermatology, Central Research Laboratory, Far Eastern State Medical University, Ministry of Health Care and Social Development of the Russian Federation, Khabarovsk, Russia.
We studied the status of proliferation processes (by Ki-67 expression) and biogenesis of free radicals (by chemiluminescence method) in skin biopsy specimens from patients with atopic dermatitis and lichen planus. The index of Ki-67-positive nuclei significantly (p<0.05) increased to 28.
View Article and Find Full Text PDFProliferative processes in the epidermis of patients with atopic dermatitis treated with thymodepressin.
Bull Exp Biol Med
May 2002
Department of Dermatology, Central Research Laboratory, Far-Eastern State Medical University, Khabarovsk.
Proliferative activity of the epidermis in skin biopsy specimens from patients with atopic dermatitis before and during therapy with thymodepressin (immunosuppressant) was studied by immunohistochemical method (by expression of Ki-67 antigen). The number of Ki-67-positive keratinocyte nuclei in atopic dermatitis considerably surpassed the corresponding parameter in intact skin (32.46 +/- 3.
View Article and Find Full Text PDFAim: To study influence of thymodepressin on the course of autoimmune cytopenia.
Material And Methods: Thymodepressin is a new synthetic hemoregulatory dipeptide (gamma-D-Glu-D-Trp). It was used for the treatment of 22 patients with autoimmune cytopenia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!